Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy E Albertson

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
FP Essentials|February 17, 2016
The Changing Drug Culture: Emerging Drugs of Abuse and Legal HighsTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Expert Opinion on Investigational Drugs|December 9, 2016
Muscarinic antagonists in early stage clinical development for the treatment of asthmaTimothy E Albertson, James A Chenoweth, Jason Y Adams, et al.
The Journal of Allergy and Clinical Immunology|October 8, 2005
No significant relationship between exhaled nitric oxide and body mass index in people with asthmaAlexandra Kazaks, Janet Y Uriu-Adams, Judith S Stern, et al.
Journal of Allergy|November 29, 2011
The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the ElderlyAmir A Zeki, Michael Schivo, Andrew Chan, et al.
Clinical Reviews in Allergy & Immunology|November 23, 2011
Bronchial thermoplasty: a new treatment paradigm for severe persistent asthmaKatherine S Cayetano, Andrew L Chan, Timothy E Albertson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|September 21, 2014
Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Timothy E Albertson, James Chenoweth, Jonathan Ford, et al.
FP Essentials|February 17, 2016
The Changing Drug Culture: Medical and Recreational MarijuanaTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
FP Essentials|February 17, 2016
The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing DrugsTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Current Opinion in Pulmonary Medicine|June 14, 2003
Advances in the management of endobronchial lung malignanciesAndrew L Chan, Ken Y Yoneda, Roblee P Allen, et al.
Journal of Toxicology. Clinical Toxicology|October 7, 2004
Regional variations in the use and awareness of the California Poison Control SystemTimothy E Albertson, R Steven Tharratt, Judy Alsop, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
FP Essentials|February 17, 2016
The Changing Drug Culture: Emerging Drugs of Abuse and Legal HighsTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Expert Opinion on Investigational Drugs|December 9, 2016
Muscarinic antagonists in early stage clinical development for the treatment of asthmaTimothy E Albertson, James A Chenoweth, Jason Y Adams, et al.
The Journal of Allergy and Clinical Immunology|October 8, 2005
No significant relationship between exhaled nitric oxide and body mass index in people with asthmaAlexandra Kazaks, Janet Y Uriu-Adams, Judith S Stern, et al.
Journal of Allergy|November 29, 2011
The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the ElderlyAmir A Zeki, Michael Schivo, Andrew Chan, et al.
Clinical Reviews in Allergy & Immunology|November 23, 2011
Bronchial thermoplasty: a new treatment paradigm for severe persistent asthmaKatherine S Cayetano, Andrew L Chan, Timothy E Albertson, et al.
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|September 21, 2014
Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Timothy E Albertson, James Chenoweth, Jonathan Ford, et al.
FP Essentials|February 17, 2016
The Changing Drug Culture: Medical and Recreational MarijuanaTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
FP Essentials|February 17, 2016
The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing DrugsTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Current Opinion in Pulmonary Medicine|June 14, 2003
Advances in the management of endobronchial lung malignanciesAndrew L Chan, Ken Y Yoneda, Roblee P Allen, et al.
Journal of Toxicology. Clinical Toxicology|October 7, 2004
Regional variations in the use and awareness of the California Poison Control SystemTimothy E Albertson, R Steven Tharratt, Judy Alsop, et al.
Pageof 13